Starna Therapeutics
Suzhou
About Starna Therapeutics
Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $74.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: starnatx.com
- Phone: 0512-6516 5336
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/starna-therapeutics-48417 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.